BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

The PD-(L)1 x VEGF Bispecific Race: Every APAC Programme in the Clinic, Counted

When the ESMO Congress opens in Madrid on 23 October, one drug class will be hard to miss. Two days in, on the evening of Sunday 25 October, the Presidenti...

October 16, 2026 | Analysis

Takeda’s First-in-Class Narcolepsy Drug ORZEYFUL Enters Japan and China Markets Following Regulatory Approvals

ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (...

October 16, 2026 | News

Danaher and NVIDIA Join Forces to Bring Autonomous AI-Powered Science into Laboratories

Danaher Corporation announced a collaboration with NVIDIA to advance autonomous science and help accelerate the pace of scientific discovery. As part of Da...

October 16, 2026 | News

China’s Hiteck Biological Pharma Licenses Next-Generation Eye Therapy to Visara for Global Development

Wuhan Hiteck Biological Pharma Co., Ltd. announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc...

October 15, 2026 | News

Waters Partners with Anthropic to Advance AI-Driven Autonomous Laboratory Workflows

Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of de...

October 15, 2026 | News

Insilico Medicine Nominates AI-Designed VAV1 Molecular Glue Degrader for Autoimmune Diseases

VAV1 (Vav guanine nucleotide exchange factor 1) plays a key role in immune cell signaling pathways, holding immense potential in autoimmune disease interve...

October 15, 2026 | News

Shanghai Ark Biopharmaceutical Secures US FDA IND Clearance for Phase II Trial of Long-Acting Influenza Prevention Drug AK0406

Shanghai Ark Biopharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK...

October 14, 2026 | News

Asieris Pharmaceuticals and Theramex Sign Over $250 Million Licensing Deal for Cervical Precancer Therapy CEVIRA

Agreement is expected to grant Theramex exclusive rights to CEVIRA® in Europe, Australia, New Zealand and Turkey, while Asieris retains rights for th...

October 13, 2026 | News

Rockwell Automation Joins Digital CMC Consortium to Accelerate Drug Development and Pharmaceutical Manufacturing

Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, announced it is a fo...

October 13, 2026 | News

12 APAC-Originated Programmes to Watch at ESMO 2026

When the ESMO Congress 2026 opens at IFEMA Madrid on Friday 23 October, the region that most European oncologists still think of as a fast follower will ho...

October 13, 2026 | News

GenScript and NVIDIA Launch Global PitchFest to Accelerate AI-Driven Drug Discovery Startups

GenScript Biotech Corporation announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups applying arti...

October 12, 2026 | News

Semaglutide Generics, Six Months In: Every Launch in India, Every Price, and Where China Stands

AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...

October 09, 2026 | Analysis

XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery

This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...

October 08, 2026 | News

QIAGEN Expands AI Push with New Tools for Biological Research and Drug Discovery

New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN D...

October 08, 2026 | News

Stay Connected